MaRS Innovation specializes in extreme early-stage seed investing for companies and technology emerging from our 15 members.

Case Studies
Curious about MI’s impact? Visit our gallery to learn about a few of the technologies we’ve been proud to accelerate.
Learn More
Our Members
MI’s portfolio draws from three universities, nine teaching hospitals and two research institutes. Learn more about our members.
Learn More
Work With Us
Through our member-exclusive funding programs and services, MI works with founders to bring their technology to market faster.
Learn More
Recent News

MaRS Innovation and KHIDI, South Korea, Creates $100M Global Commercialization Partnership

Today MaRS Innovation (MI) and the Korea Health Industry Development Institute (KHIDI) signed a five year global partnership agreement to commercialize the latest advances in biomedical and healthcare innovations which is expected to generate …

Acquisition of First Compound from Triphase by Celgene

Toronto-based MaRS Innovation announced today that one of its leading portfolio companies, Triphase Accelerator Corporation (Triphase), has agreed to sell assets relating to its first investigational compound, marizomib (MRZ) to U.S.-based Celgene Corporation, through …

Zucara Therapeutics Receives Cash Injection to Advance Novel Diabetes Drug Therapy to Prevent Hypoglycemia

VANCOUVER and TORONTO, Canada (November 3, 2016) — Zucara Therapeutics Inc., a pre-clinical life sciences company advancing a novel long-term therapeutic approach to prevent hypoglycemia in patients with diabetes, announced it has received a …

MaRS Innovation shifted my perspective from BlueDot's research to its potential as a global business. They worked with me to incorporate the company, develop a business plan and model suitable for a social enterprise, and hire key talent, while supporting me through BlueDot’s early stages of growth and development.
Kamran Khan, MD, MPH
Founder / BlueDot
MaRS Innovation is doing some great things with great people. The honest war stories from seasoned entrepreneurs, tough love from advisors and direct support from people on the team are a rare find. MI and UTEST are and continue to be the reasons we're thriving as a business.
Marissa Wu
Co-Founder / Onyx Motion
MaRS Innovation understood the value of my invention and saw its potential when others didn’t (they’re starting to now!). I’m grateful for the investment and mentoring I received through the UTEST program.
James Colliander, PhD
Co-Founder / Crowdmark
The UTEST program and MaRS Innovation have been fantastic for TrendMD; we would not be where we are today without them. Both from a strategic and financial perspective, UTEST definitely served as the initial spark that was crucial for getting us off the ground.
Paul Kudlow, MD
Founder / TrendMD
MaRS Innovation’s unique ecosystem allows innovators and researchers to keep the high impact of their innovation while enabling it with frameworks for commercialization. Their dedicated expert team allowed us to launch, structure and scale our company both in Canada and in the rest of the world while allowing us to maintain our research and academic mandates.
Hossein Rahnama, PhD
Founder / Flybits
There is nothing more powerful I can say than the simple fact that we would not even exist as a company were it not for the UTEST program.
William Walmsley
Co-Founder / Whirlscape
MaRS Innovation was a vital partner as we refined our technology, our business model and our go-to-market strategy. Without their support, and the support of UTEST, we would not be in the position we are today.
Craig Boutilier, PhD
Co-Founder / Granata Decision Systems
The guidance and resources that Mars Innovation has provided significantly excelled Nvest forward. We have appeared on major newspapers, formed important relationships with strategic partners, and developed stronger user acquisition strategy. Our progress and success to date and trajectory going forward could not have been achieved without the combined help of MaRS Innovation and UTEST.
Fredrick Zhou
Co-Founder / NVest